The Global Tyrosine Kinase Inhibitors Market is poised for steady expansion. Valued at USD 63.58 billion in 2024, the market is projected to reach USD 100.57 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.90% from 2025 to 2032. This article provides a thorough analysis of market dynamics, segmentation, drivers, challenges, and competitive insights, drawing...